NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Kemin Industries, Inc.
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Cortical Studios Wins Top International Film Award for CLOSTAT™ A Next Generation Probiotic, Explaining Kemin Industries’ Active Microbial - Kemin is pleased to congratulate the bioinformatics company Cortical Studios for its award-winning film, CLOSTAT™ - CorticalStudios.nl / Kemin.com
Cortical Studios Wins Top International Film Award for CLOSTAT™ A Next Generation Probiotic, Explaining Kemin Industries’ Active Microbial

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2014/04/09 - Kemin is pleased to congratulate the bioinformatics company Cortical Studios for its award-winning film, CLOSTAT™ - CorticalStudios.nl / Kemin.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Kemin is pleased to congratulate the bioinformatics company Cortical Studios for its award-winning film, CLOSTAT™ a next generation probiotic, at the New York Festivals® International Television & Film Awards™ ceremony on April 8 at the annual National Association of Broadcasters Show in Las Vegas.

The New York Festivals® International Television & Film Awards™ honors digital communication excellence across the globe. With finalists selected from 36 countries, Cortical Studios took home gold in the instruction and education category and bronze in animation.

Its winning video, produced in partnership with Kemin Industries, communicates the detailed complexity of the company’s highly technical product CLOSTAT.

“Earning a Gold World Medal at this prestigious film festival is a huge achievement,” said Dr. R Chanthirasekaran, Kemin global product manager of CLOSTAT. “We are pleased to congratulate and thank Cortical Studios for their work that allowed us to share the benefits of CLOSTAT, a unique and cutting edge probiotic, with our customers in an easy to understand format.”

CLOSTAT is an active microbial that works to effectively manage harmful bacteria from the gut to create a balanced microbial ecosystem. CLOSTAT contains a proprietary, patented strain of Bacillus subtilis PB6, isolated by Kemin scientists from the intestine of a healthy chicken. It works in harmony with the animal and does not contribute to antibiotic resistance nor residue issues.

“It is well-known that intestinal integrity and microbial balance are important factors when it comes to an animal’s health, and its ability to reach full genetic potential,” said Dr. Chanthirasekaran. “CLOSTAT is a natural solution and helps producers maximize profits by supplying high quality meat to a protein hungry market.”

International research and its continuous use as a preventative application in the field, indicate that CLOSTAT works effectively to maintain a balanced gastrointestinal tract, reducing intestinal Clostridial disorders while supporting the responsible use of antibiotics.

About Kemin Inspired Molecular Solutions™
Kemin (kemin.com) provides “inspired molecular solutions” specifically developed to provide nutrition and health benefits for humans and animals. Committed to feed and food safety, Kemin maintains top-of-the-line manufacturing facilities where approximately 500 specialty ingredients are made for the global feed and food industries as well as the health, nutrition and beauty markets. A privately held, family-owned and operated company, Kemin has nearly 2,000 employees and operates in more than 90 countries with manufacturing facilities in Belgium, Brazil, China, India, Italy, Singapore, South Africa and the United States.

About Cortical Studios
Cortical Studios (corticalstudios.nl) specializes in creating 3D animations to explain such things as the complex mechanism of medical drugs to a wide target group. Cortical Studios has produced a large number of films for a variety of biotechnology and pharmaceutical companies (e.g. Pfizer, Johnson & Johnson, and Shire). Our customers also include various hospitals and universities (the University of Amsterdam, Sanquin and the Academic Medical Centre).

Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]  / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Cortical Studios Wins Top International Film Award for CLOSTAT™ A Next Generation Probiotic, Explaining Kemin Industries’ Active Microbial

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Tin Mariën - Kemin.com 
+32 14 28 62 60 tin.marien[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

LYSARC Partners with Veeva to Accelerate Innovation for Lymphoma Treatments
PharmaEssentia Selects Veeva Data Cloud to Support Launch of Novel Therapy for Rare, Chronic Blood Cancers
Transgene and NEC Announce Positive Preliminary Data from Phase I Studies of TG4050 - A Novel Individualized Neoantigen Cancer Vaccine
DSM Plans New Production Site for Bovaer® in Dalry, Scotland
Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  RightITnow, Inc.

Visit  JobsWare.com





 
  ©2022 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)